Dresser, G.K., J.D. Spence, and D.G. Bailey. 2000. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clinical Pharmacokinetics 38 (1): 41-57.

Lui, E.M.K., C. Suzuki, and J.R. Bend. 2000. Countries: Canada (Chapter 25). Information Resources in Toxicology. 3rd ed. P. Wexler. New York: Academic Press. 583-598.

Moorthy, B., K.M. Parker, C.V. Smith, J.R. Bend, and S.E. Welty. 2000. Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole. The Journal of Pharmacology and Experimental Therapeutics 292 (2): 553-560.

Hoque, N., M.A. Cook, and M. Karmazyn. 2000. Inhibition of a₁-adrenergic-mediated responses in rat ventricular myocytes by adenosine A₁ receptor activation: Role of the K_ATP channel. The Journal of Pharmacology of Pharmacology and Experimental Therapeutics 294 (2): 770-777.

Hammond, J.R. 2000. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: Species differences and transporter subtype selectivity. Naunyn-Schmiedeberg's Archives of Pharmacology 361: 373-382.

Feuvray, D., and M. Karmazyn. 1999. Échangeur Na⁺/H⁺ et régulation du pH des myocytes cardiaques: de la physiologie à la physiopathologie. médecine/sciences 15: 322-328.

Gan, T.X., S. Chakrabarti, and M. Karmazyn. 1999. Modulation of Na⁺/H⁺ exchange isoform (NHE-1) mRNA expression in isolated rat hearts. American Journal of Physiology 277 (46): H993-H998.

Hoque, N., M.A. Cook, and M. Karmazyn. 2000. Inhibition of a₁-adrenergic-mediated responses in rat ventricular myocytes by adenosine A₁ receptor activation: Role of the K_ATP channel. The Journal of Pharmacology of Pharmacology and Experimental Therapeutics 294 (2): 770-777.

Karmazyn, M. 1999. Expression and role of the Na⁺/H⁺ exchanger in myocardial injury: From the ischaemic and reperfused myocardium to congestive heart failure. European Heart Journal Supplements 1 (Supp K): K38-K44.

Karmazyn, M. 1999. Mechanisms of protection of the ischemic and reperfused myocardium by sodium-hydrogen exchange inhibition. Journal of Thrombosis and Thrombolysis 8: 33-38.

Karmazyn, M. 1999. The Myocardial Sodium-Hydrogen Exchanger: An Adaptive Mechanism to Ischemia-Induced Acidosis Resulting in Tissue Injury (Chapter 9). Adaptation Biology and Medicine, Vol. 2. K. Pandolf, N. Takeda, and P.K. Singal. New Delhi, India: Narosa Publishing House.

Karmazyn, M. 2000. Pharmacology and clinical assessment of cariporide for the treatment coronary artery diseases. Expert Opinion on Investigational Drugs 9 (5): 1099-1108.

Karmazyn, M. 1999. The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury: From amiloride to cariporide. Annals of the New York Academy of Sciences 874: 326-334.

Karmazyn, M., X.T. Gan, R.A. Humphreys, H. Yoshida, and K. Kusumoto. 1999. The myocardial Na⁺-H⁺ exchange: Structure, regulation, and its role in heart disease. Circulation Research 85: 777-786.

Mathur, S., P. Farhangkhgoee, and M. Karmazyn. 1999. Cardioprotective effects of propofol and sevoflurane in ischemic and reperfused rat hearts: Role of K_ATP channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (Cariporide). Anesthesiology 91: 1349-1360.

Neviere, R.R., G. Cepinskas, W.S. Madorin, N. Hoque, M. Karmazyn, W.J. Sibbald, and R. Kvietys. 1999. LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: role of myocytes. American Journal of Physiology 277 (46): H885-H892.

Yoshida, H., and M. Karmazyn. 2000. Na⁺/H⁺ exchange inhibition attenuates hypertrophy and heart failure in 1-week postinfarcted rat myocardium. American Journal of Physiology 278: H300-H304.

Lui, E.M.K. 2000. Milk Thistle. Herbs: Everyday Reference for Health Professionals. F. Chandler. Ottawa, Ontario: Canadian Pharmacists Association. 158-161.

Lui, E.M.K., C. Suzuki, and J.R. Bend. 2000. Countries: Canada (Chapter 25). Information Resources in Toxicology. 3rd ed. P. Wexler. New York: Academic Press. 583-598.

Philp, R.B. 1999. Cadmium content of the marine sponge Microciona prolifera, other sponges, water and sediment from the eastern Florida panhandles: possible effects on Microciona cell aggregation and potential roles of low pH and low salinity. Comparative Biochemistry and Physiology 124 (Part C): 41-49.

Birkett, S.H., and D.J. Rapport. 1999. A Stress-Response Assessment of the North-Western Gulf of Mexico Ecosystem. The Gulf of Mexico Large Marine Ecosystem: Assessment, Sustainability, and Management. H. Kempf, K. Steidinger, and K. Sherman. Oxford: Blackwell Science. 438-458.

Costanza, R., H. Daly, C. Folke, P. Hawken, C.S. Holling, A.J. McMichael, D. Pimentel, and D.J. Rapport. 2000. Managing our environmental portfolio. Bioscience 50 (2): 149-155.

Patel, A., D.J. Rapport, L. Vanderlinden, and J. Eyles. 1999. Forests and societal values: comparing scientific and public perceptior of forest health. The Environmentalist 19: 239-249.

Rapport, D.J. 2000. Ecological footprints and ecosystem health: complementary approaches to a sustainable future. Ecological Economics 32: 367-370.

Rapport, D.J. 1999. Ecosystem health: The concept, the ISEH, and the important tasks ahead. Ecosystem Health 5: 82-90.

Rapport, D.J. 1999. Epidemiology and ecosystem health: Natural bridges. Ecosystem Health 5 (3): 174-180.

Rapport, D.J. 1999. On transformation from healthy to degraded aquatic ecosystems. Aquatic Ecosystem Health and Management 2: 97-103.

Rapport, D.J., N. Christensen, J.R. Karr, and G.P. Patil. 1999. The Centrality of Ecosystem Health in Achieving Sustainability in the 21st Century: Concepts and New Approaches to Environmental Management. Transactions of the Royal Society of Canada, Vol. IX. 6th ed. Toronto, ON: University of Toronto Press. 3-40.

Rapport, D.J., M. Hilden, and K. Weppling. 2000. Restoring the health of the earth's ecosystems: A new challenge for the earth sciences. Episodes 23 (1): 12-19.

Rapport, D.J., and W. Whitford. 1999. How ecosystems respond to stress: Common properties of arid and aquatic systems. BioScience 49 (3): 193-203.

Dresser, G.K., J.D. Spence, and D.G. Bailey. 2000. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clinical Pharmacokinetics 38 (1): 41-57.